NasdaqCM - Delayed Quote USD

ProMIS Neurosciences, Inc. (PMN)

0.5000
0.0000
(0.00%)
At close: June 2 at 4:00:00 PM EDT
0.5090
+0.01
+(1.80%)
After hours: June 2 at 7:29:44 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
--
0
0
Operating Expense
20,610.9210
16,827.4780
--
23,379.9120
8,291.0930
Operating Income
-20,610.9210
-16,827.4780
--
-23,379.9120
-8,291.0930
Net Non Operating Interest Income Expense
0
-76.7750
--
-282.0640
-416.2860
Other Income Expense
19,676.9800
19,683.1260
--
5,599.7130
-1,082.7270
Pretax Income
-933.9410
2,778.8730
--
-18,062.2630
-9,790.1060
Net Income Common Stockholders
-933.9420
2,778.8730
--
-18,062.2630
-9,790.1060
Diluted NI Available to Com Stockholders
-933.9420
2,778.8730
--
-18,062.2630
-9,790.1060
Basic EPS
0.09
0.11
-1.07
-2.41
-1.69
Diluted EPS
0.09
0.11
-1.07
-2.41
-1.69
Basic Average Shares
29,749.2720
25,919.9650
12,292.7070
7,502.6090
5,785.6170
Diluted Average Shares
30,291.0380
26,461.7310
12,292.7070
7,502.6090
5,785.6170
Total Operating Income as Reported
-20,610.9220
-16,827.4780
--
-23,379.9120
-8,291.0930
Total Expenses
20,610.9210
16,827.4780
--
23,379.9120
8,291.0930
Net Income from Continuing & Discontinued Operation
-933.9420
2,778.8730
--
-18,062.2630
-9,790.1060
Normalized Income
-23,529.5510
-16,415.3825
--
-23,546.4510
-8,694.4700
Interest Income
--
--
--
--
4.7317
Interest Expense
0
76.7750
--
282.0640
416.2860
Net Interest Income
0
-76.7750
--
-282.0640
-416.2860
EBIT
-933.9410
2,855.6480
--
-17,780.1990
-9,373.8200
EBITDA
-933.9410
2,855.6480
--
-17,768.9830
-9,327.9950
Reconciled Depreciation
4.6970
0
--
11.2160
45.8250
Net Income from Continuing Operation Net Minority Interest
-933.9420
2,778.8730
--
-18,062.2630
-9,790.1060
Total Unusual Items Excluding Goodwill
22,595.6090
22,581.4770
--
5,484.1880
-1,095.6360
Total Unusual Items
22,595.6090
22,581.4770
--
5,484.1880
-1,095.6360
Normalized EBITDA
-23,529.5500
-19,725.8290
--
-23,253.1710
-8,232.3590
Tax Rate for Calcs
0
0.0002
--
0
0
Tax Effect of Unusual Items
0
3,387.2215
--
0
0
12/31/2021 - 1/10/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TSBX Turnstone Biologics Corp.
0.3127
-2.31%
 
ELDN Eledon Pharmaceuticals, Inc.
3.0600
+2.00%
 
MTVA MetaVia Inc.
0.6545
+0.66%
 
OBIO Orchestra BioMed Holdings, Inc.
3.1600
+10.88%
 
APS.TO Aptose Biosciences Inc.
2.3700
+0.42%
 
IVA Inventiva S.A.
3.3900
-0.07%
 
DMN.MU Diamyd Medical AB
0.8290
+2.22%
 
4XC1.SG KalVista Pharmaceuticals Inc
11.10
+9.90%
 
PHGE BiomX Inc.
0.5222
+6.57%
 
CALC CalciMedica, Inc.
1.6400
-4.09%